Patents by Inventor Ronald N. Marcus

Ronald N. Marcus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
    Publication number: 20240156802
    Abstract: Provided herein are methods of treating a disorder ameliorated by activating muscarinic receptors in a patient 55 years or older in need thereof. The method comprises administering a total daily dose of between 25 and 200 mg xanomeline and/or a salt thereof and between 5 and 30 mg of a salt of trospium to the patient, such as a total daily dose of between 100 and 200 mg xanomeline and/or a salt thereof and between 20 and 30 mg of a salt of trospium. The present disclosure also provides a method for treating dementia-related psychosis and a method decreasing the risk of relapse in a patient having dementia-related psychosis.
    Type: Application
    Filed: August 23, 2023
    Publication date: May 16, 2024
    Inventors: Andrew MILLER, Stephen BRANNAN, Inderjit KAUL, Ronald N. MARCUS, David S. SMALL
  • Nefazodone: use in migraine prophylaxis
    Patent number: 5854248
    Abstract: Nefazodone and its pharmaceutically acceptable salts are useful in prophylactic treatment of recurrent headache disorders, as, in particular, vascular and migraine headaches.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: December 29, 1998
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ronald N. Marcus, Neil M. Sussman
  • Nefazodone: use in treating post traumatic stress disorder
    Patent number: 5852020
    Abstract: Nefazodone and its pharmaceutically acceptable salts are useful in alleviation of post traumatic stress disorder.
    Type: Grant
    Filed: July 31, 1997
    Date of Patent: December 22, 1998
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ronald N. Marcus, Brenda Martini